Sorrento Therapeutics Current Ratio 2008-2021 | SRNE

Sorrento Therapeutics current ratio from 2008 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Sorrento Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2021-06-30 $0.16B $0.18B 0.86
2021-03-31 $0.27B $0.10B 2.77
2020-12-31 $0.09B $0.10B 0.89
2020-09-30 $0.11B $0.09B 1.15
2020-06-30 $0.06B $0.09B 0.60
2020-03-31 $0.05B $0.09B 0.55
2019-12-31 $0.07B $0.12B 0.59
2019-09-30 $0.07B $0.11B 0.60
2019-06-30 $0.09B $0.11B 0.84
2019-03-31 $0.12B $0.07B 1.60
2018-12-31 $0.18B $0.06B 2.91
2018-09-30 $0.15B $0.08B 1.76
2018-06-30 $0.06B $0.04B 1.39
2018-03-31 $0.04B $0.05B 0.71
2017-12-31 $0.03B $0.08B 0.38
2017-09-30 $0.05B $0.08B 0.54
2017-06-30 $0.06B $0.08B 0.76
2017-03-31 $0.04B $0.07B 0.59
2016-12-31 $0.09B $0.08B 1.18
2016-09-30 $0.07B $0.04B 1.99
2016-06-30 $0.15B $0.06B 2.40
2016-03-31 $0.07B $0.03B 2.52
2015-12-31 $0.14B $0.03B 4.57
2015-09-30 $0.13B $0.03B 4.79
2015-06-30 $0.05B $0.01B 5.19
2015-03-31 $0.06B $0.01B 6.61
2014-12-31 $0.07B $0.01B 7.73
2014-09-30 $0.05B $0.01B 5.27
2014-06-30 $0.05B $0.01B 7.44
2014-03-31 $0.03B $0.01B 5.95
2013-12-31 $0.03B $0.01B 5.96
2013-09-30 $0.01B $0.00B 2.97
2013-06-30 $0.01B $0.00B 3.99
2013-03-31 $0.01B $0.00B 8.27
2012-12-31 $0.01B $0.00B 8.99
2012-09-30 $0.01B $0.00B 12.13
2012-06-30 $0.01B $0.00B 18.59
2012-03-31 $0.00B $0.00B 7.93
2011-12-31 $0.00B $0.00B 9.90
2011-09-30 $0.00B $0.00B 4.97
2011-06-30 $0.00B $0.00B 7.08
2011-03-31 $0.01B $0.00B 4.24
2010-12-31 $0.01B $0.00B 9.19
2010-09-30 $0.00B $0.00B 4.83
2010-06-30 $0.00B $0.00B 9.69
2010-03-31 $0.00B $0.00B 14.66
2009-12-31 $0.00B $0.00B 9.79
2009-09-30 $0.00B $0.00B 18.54
2009-06-30 $0.00B $0.00B 7.69
2009-03-31 $0.00B $0.00B 9.76
2008-12-31 $0.00B $0.00B 0.00
2008-09-30 $0.00B $0.00B 2187.50
2008-06-30 $0.00B 0.00
2008-03-31 $0.00B $0.00B 1.46
2007-12-31 $0.00B $0.00B 6.64
2007-09-30 $0.00B 0.00
2007-06-30 $0.00B 0.00
2007-03-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.039B $0.040B
Sorrento Therapeutics, Inc. is a biopharmaceutical company. It is focused primarily on the acquisition, discovery, development and commercialization of proprietary oncology therapeutics. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic disease and infectious disease. Sorrento Therapeutics, Inc. is based in San Diego, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.416B 8.62
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.526B 21.21
Biohaven Pharmaceutical Holding (BHVN) United States $9.249B 0.00
Emergent Biosolutions (EBS) United States $2.705B 6.53
Arcus Biosciences (RCUS) United States $2.404B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.873B 0.00
Myovant Sciences (MYOV) United Kingdom $1.831B 0.00
Zymeworks (ZYME) Canada $1.080B 0.00
Ambrx Biopharma (AMAM) United States $0.464B 0.00
SQZ Biotechnologies (SQZ) United States $0.372B 0.00
Enzo Biochem (ENZ) United States $0.161B 15.86